CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Excelsior Biopharma Inc Company Snapshot
Excelsior Biopharma Inc operates in the Drugs, proprietaries, and sundries sector. In addition to historical fundamental analyses, the complete report available to purchase compares Excelsior Biopharma Inc with three other companies in this sector in Taiwan: Maywufa Company Ltd. (2017 sales of 1.58 billion Taiwanese Dollars [US$52.70 million] of which 59% was Hairdressing Dept.), Sharehope Medicine Company Limited (2.62 billion Taiwanese Dollars [US$87.55 million] of which 48% was Medicine Department), and Arich Enterprise Co Ltd (1.20 billion Taiwanese Dollars [US$40.30 million] ).

Sales Analysis. Excelsior Biopharma Inc reported sales of 1.72 billion Taiwanese Dollars (US$57.40 million) for the year ending December of 2017. This represents an increase of 11.8% versus 2016, when the company's sales were 1.54 billion Taiwanese Dollars. Sales at Excelsior Biopharma Inc have increased during each of the previous five years (and since 2012, sales have increased a total of 105%).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Excelsior Biopharma Inc
  Stock Performance Chart for Excelsior Biopharma Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (5/18/2018): 72.50
(Figures in Taiwanese Dollars)
1 Week 0.4%   13 Weeks -7.4%  
4 Weeks 2.5%   52 Weeks -5.2%  
 
Excelsior Biopharma Inc Key Data:
  Ticker: 6496 Country: Taiwan
  Exchanges: TAI Major Industry: Health Care Equipment & Services
    Sub Industry: Drugs, Proprietaries, & Sundries
  2017 Sales 1,715,539,000
(Year Ending Jan 2018).
Employees: 116
  Currency: Taiwanese Dollars Market Cap: 3,383,357,500
  Fiscal Yr Ends: December Shares Outstanding: 46,667,000
  Share Type: Gu Closely Held Shares: 32,392,000
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.